Table 1.

Parameters for the economic evaluation of RV1 and RV5 in Guatemala

Parameter	RV1	RV5
Price per dose (US $)	7.00	21.79
No. of doses	2	3
Price for all doses (US $)	14.00	65.37
Efficacy against diarrhea of any severity	70% (95% CI 46–84)	74% ( 95% CI 67–80)
Efficacy against severe rotavirus-related diarrhea	85% (95% CI 72–94)	98% (95% CI 88–100)
Efficacy against hospitalization	85% (95% CI 70–94)	95% (95% CI 91–97)
Security (intussusception)	No increase in incidence up to 31 d postvaccination	No increase in incidence up to 42 d postvaccination

CI, confidence interval; RV1 and RV5, rotavirus vaccines.Source. Ministerio de Salud Pública y Asistencia Social (2012).